Innovative MedTech, Inc. Faces Mounting Losses and High Costs Amid Strategic Partnerships

Company Overview
Innovative MedTech, Inc. (PINK: IMTH), a Delaware-based provider of health and wellness services, is actively engaged in the healthcare sector with a focus on technology and adult day services. The company operates through its subsidiary, SarahCare, which offers adult day care services across multiple locations.

Recent Developments
- In December 2024, a new Memorandum of Understanding (MOU) was signed with Texas A&M University College of Dentistry to collaborate on healthcare initiatives, particularly concerning the treatment of oral thrush.
- Consulting agreements were recently established with specialists in wound care to support expansion into that market by utilizing advanced wound care technologies.
- However, the partnership with Near Infrared Imaging, Inc. for the distribution of vein visualization technology has been terminated as of December 2024.

Income Statement Analysis
- Positive Aspects:
- The company successfully managed to issue stock in lieu of cash for services, raising capital by converting services into equity.
- Discontinued operations showed increased revenue of $843,080 for six months ended December 31, 2024, compared to $913,399 in the same period in 2023, despite reductions in operating expenses and losses.
- Negative Aspects:
- Net losses have escalated significantly, recording a net loss of $1,124,333 for Q4 2024 versus a loss of $188,145 in the prior year, largely due to increased consulting fees and a surge in operational costs.
- Total operating expenses rose sharply to $1,074,176 for the quarter ended December 31, 2024, a staggering 1045% increase from $93,834 in 2023, reflecting high consulting and stock-based compensation costs.

Key Financial Statistics
- For Q4 2024:
- Revenue: $0
- Operating Expenses: $1,074,176
- Net Loss: $(1,124,333)
- Basic and diluted earnings per share: $(0.04)
- For the six months ending December 31, 2024:
- Revenue: $0
- Operating Expenses: $1,971,672
- Net Loss: $(2,007,864)
- Current assets as of December 31, 2024: $1,132,186
- Current liabilities: $5,976,654
- Accumulated deficit: $(46,569,074)

Conclusion
Innovative MedTech, Inc. is in a precarious position, facing significant challenges with mounting losses and high operational costs. The company is seeking additional capital for its continuation and growth, making its future dependant on the ability to secure financing and manage operational efficiency.